Table 2.

Correlation analysis between EZH2 and biomarkers of immune cells in HCC determined using the GEPIA and TIMER databases.

		GEPIA		TIMER
		R	p	R	p
B cells	CD19	0.110	1.10 × 10−1	0.244	1.92 × 10−6
	CD79A	0.083	7.90 × 10−5	0.131	1.18 × 10−2
CD8+ T cells	CD8A	0.200	1.40 × 10−5	0.180	5.05 × 10−4
	CD8B	0.220	7.70 × 10−3	0.168	1.17 × 10−3
CD4+ T cells	CD4	0.140	8.20 × 10−1	0.217	2.44 × 10−5
M1 macrophages	NOS2	−0.012	0.00 × 10−0	0.003	9.48 × 10−1
	IRF5	0.440	5.00 × 10−1	0.482	5.97 × 10−23
	PTGS2	0.035	2.80 × 10−3	0.088	9.22 × 10−2
M2 macrophages	CD163	0.160	2.40 × 10−4	0.101	5.21 × 10−2
	VSIG4	0.190	2.00 × 10−3	0.100	5.41 × 10−2
	MS4A4A	0.160	8.30 × 10−1	0.102	5.07 × 10−2
Neutrophils	CEACAM8	0.011	2.40 × 10−11	0.094	6.95 × 10−2
	ITGAM	0.340	2.20 × 10−1	0.289	1.44 × 10−8
	CCR7	0.064	2.40 × 10−5	0.083	1.10 × 10−1
Dendritic cells	HLA-DPB1	0.220	9.00 × 10−2	0.154	2.91 × 10−3
	HLA-DQB1	0.088	1.70 × 10−5	0.146	4.87 × 10−3
	HLA-DRA	0.220	1.20 × 10−4	0.167	1.22 × 10−3
	HLA-DPA1	0.200	7.40 × 10−4	0.158	2.28 × 10−3
	CD1C	0.170	6.50 × 10−8	0.114	2.85 × 10−2
	NRP1	0.280	1.10 × 10−6	0.263	2.67 × 10−7
	ITGAX	0.250	1.10 × 10−1	0.348	5.15 × 10−12

HCC: hepatocellular carcinoma; EZH2: Enhancer of Zeste Homolog 2; p values less than 0.05 are shown in bold.